MedPath

BeC Racepinephrine

Approved
Approval ID

30e35101-fa7b-536f-e063-6394a90a6e53

Product Type

HUMAN OTC DRUG LABEL

Effective Date

May 7, 2025

Manufacturers
FDA

Blue Echo Care LLC

DUNS: 117048847

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Racepinephrine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code73117-518
Application NumberM012
Product Classification
M
Marketing Category
C200263
G
Generic Name
Racepinephrine
Product Specifications
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 7, 2025
FDA Product Classification

INGREDIENTS (5)

CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
ASCORBIC ACIDInactive
Code: PQ6CK8PD0R
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
RACEPINEPHRINE HYDROCHLORIDEActive
Quantity: 11.25 mg in 0.5 mL
Code: 336096P2WE
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BeC Racepinephrine - FDA Drug Approval Details